4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
US7579349B2 · kind B2 · utility
16Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2004 |
| Grant date | Aug 25, 2009 |
| Priority date | — |
| Expiry date | Nov 28, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of Formula (I); wherein the substituents are as defined in the text for use in modulating insulin-like growth factor 1 receptor activity in a warm blooded animal such as man.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.